Applied Nutrition reports strong FY25 results, raises FY26 outlook

Applied Nutrition plc reported robust financial results for the year ending July 31, 2025, with revenue increasing 24% year-on-year to £107 million and adjusted EBITDA growing 19%, both exceeding market expectations. Net cash also surpassed forecasts at £18.5 million. The company attributed its strong performance to a successful multi-pillar growth strategy and anticipates FY26 revenue will exceed current market expectations of £112.4 million, signaling continued positive momentum and confidence in its long-term growth and profitability.

Analysis

Applied Nutrition plc (APNA) has announced preliminary financial results for the fiscal year ending July 31, 2025, that significantly exceed consensus market expectations. The company reported a 24% year-over-year increase in revenue to £107 million, driven by robust second-half trading that accounted for approximately £60 million. Concurrently, adjusted EBITDA grew by approximately 19% from the prior year's £26 million, and the balance sheet was strengthened with a net cash position of £18.5 million, also surpassing forecasts. This performance, which exceeds guidance provided at the company's IPO, is attributed to the successful execution of a multi-pillar global growth strategy. Looking forward, management has issued positive guidance, projecting that revenue for the fiscal year 2026 will exceed the current market expectation of £112.4 million, signaling sustained confidence in its B2B-focused business model and new product development pipeline to drive long-term growth and profitability.

Key Decisions for Investors

• Given the strong beat on revenue and EBITDA for FY25 and the upward revision to FY26 guidance, investors should view these results as a strong positive signal of the company's growth acceleration and operational execution.
• Anticipate positive revisions to analyst consensus estimates and price targets, which could act as a near-term catalyst for the stock's performance.
• While the growth narrative is compelling, investors should monitor the audited results on November 10, 2025, paying close attention to profit margins, as the reported EBITDA growth of 19% slightly lagged revenue growth of 24%.